CANNAVID - Study on the impact of Covid-19 on use, practices and health among regular cannabis users

Head :
Roux Perrine , UMR 1252 SESSTIM

Last update : 05/06/2021 | Version : 1 | ID : 73876

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Study on the impact of Covid-19 on use, practices and health among regular cannabis users
Sign or acronym CANNAVID
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL 2217595
General Aspects
Medical area Infectious diseases
Psychology and psychiatry
Study in connection with Covid-19 Yes
Pathology (details) addiction, inflammatory diseases, psychiatric disorders, cardiac or vascular disease, obesity or other metabolic disease, respiratory diseases, infectious diseases, cancer
Health determinants Addictions
Healthcare system and access to health care services
Lifestyle and behavior
Occupation
Social and psychosocial factors
Keywords Cannabis and other illicit substances, Covid-19, mental health, pain, lockdown
Scientific investigator(s) (Contact)
Name of the director Roux
Surname Perrine
Address Sciences Economiques et Sociales de la Santé et Traitement de l'Information Médicale<br>Faculté de médecine<br>27 bd Jean Moulin<br>13005 Marseille
Phone +33(0)4 13 73 22 78
Email perrine.roux@inserm.fr
Unit UMR 1252 SESSTIM
Organization Inserm
Collaborations
Participation in projects, networks and consortia No
Funding
Funding status Mixed
Details no funding for this study
Governance of the database
Sponsor(s) or organisation(s) responsible Bus 31/32 Association (CSAPA, CAARUD)
Organisation status Private
Presence of scientific or steering committees Yes
Labelling and database evaluation internal audit
Additional contact
Name of the contact Lebrun Gadelius
Surname Maela
Address Bus 31/32<br>4 avenue Rostand <br>13003 Marseille<br>
Phone 04 95 04 56 06
Email maela.lebrun@bus3132.org
Organization Bus 31/32
Main features
Type of database
Type of database Study databases
Study databases (details) Repeated cross-sectional studies (except case control studies)
Database recruitment is is made on the basis of: Another treatment or procedure
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Promotion of the study via different websites aimed at cannabis users (patient or harm reduction associations, social network).
Database objective
Main objective Evaluate the impact of the different lockdowns on cannabis use practices among daily users, psychoactive substance use and the onset of related symptoms (withdrawal, pain, sleep disorders, anxiety, depression).
Inclusion criteria Daily cannabis users or individuals having taken part in the previous CANNAVID series for questionnaires completed from the second lockdown;
Aged over 18 years;
Able to understand French;
Residing in France;
Agreeing to take part in the study and having expressed their non-objection.
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered General population
Pathology
Gender Male
Woman
Other
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Date of last collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals First lockdown: 4,019 participants
Data
Database activity Current data collection
Type of data collected Declarative data
Declarative data (detail) Internet self-questionnaire
Details of collected declarative data Sociodemographic characteristics (age, gender, level of education, accommodation, parenthood), before and during the lockdown (accommodation, professional activity, recourse to a food bank); psychoactive substance use (use, supply, storage, quantities used, adverse reactions, withdrawal symptoms, substance analyses, penalties due to cannabis use) before and during the lockdown, changes in use between lockdowns; health status and practices (chronic disorders, treatments, symptoms of Covid-19, overdoses, medical appointments, Hospital Anxiety and Depression scale before and during the lockdown.
Presence of a biobank No
Health parameters studied Health event/morbidity
Quality of life/health perception
Quality of life/perceived health (detail) state of health before and during the lockdown
Procedures
Data collection method Data collection via the internet
Classifications used Hospital Anxiety and Depression scale, withdrawal symptoms (American Psychiatric Association 2013), ICD-10
Quality procedure(s) used methodology centre specialised in epidemiological studies
Participant monitoring Yes
Details on monitoring of participants please state whether the participant took part in the first questionnaire series
Followed pathology F10-F19 - Mental and behavioural disorders due to psychoactive substance use
Links to administrative sources No
Promotion and access
Promotion
Link to the document https://www.cairn.info/revue-psychotropes-2020-2-page-141.htm
Description CANNAVID survey: Changes in cannabis use among daily users during the Covid-19 pandemic
Other information Preliminary results available on: https://infogram.com/cannavid-resultats-preliminaires-1hzj4onmnjlo2pw?live
Access
Dedicated website https://cannavid.limequery.com/439624?lang=fr
Presence of document that lists variables and coding procedures Yes
Terms of data access (charter for data provision, format of data, availability delay) Methods for accessing the database are in the process of being defined
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05